Controversy over domestic drugmaker Medigen’s COVID-19 vaccine could have been avoided had the company published data on its phase 2 clinical trials in international journals, National Taiwan University (NTU) College of Public Health vice dean Tony Chen (陳秀熙) said yesterday.
The government on Sunday granted emergency use authorization (EUA) to the Medigen jab after an expert panel said that antibody levels in the blood of phase 2 trial participants met local standards.
However, critics said that the experts’ reasoning was not convincing because not all trial data had been publicized and that Taiwan is the only country to conditionally approve a vaccine that has not yet passed phase 3 clinical trials.
Medigen on Tuesday said it had received approval to conduct phase 3 trials on 1,000 people in Paraguay.
Chen yesterday said that the Paraguay trials’ methodology and safety precautions would be well within international standards, but whether the vaccine could provide sufficient protection, especially against highly infectious variants of SARS-CoV-2, could only be determined with additional trials.
Chen said that he believes the expert panels’ assessment on which the EUA is based, but that the company lacks sufficient credibility based on publication in scientific journals.
“Trial data of the COVID-19 vaccines that are in use worldwide — AstraZeneca, Pfizer-BioNTech, Moderna, Johnsons & Johnson and Novavax, among others — have been published in credible international journals,” Chen said, adding that this, not the transparency of the approval process in various countries, gives them credibility.
Even China last year publicized the phase 2 trial results of the Sinovac COVID-19 vaccine, he said.
The publication of trial data is a critical step that the Medigen vaccine must take, Chen said, adding that verification by the international medical community would be crucial to calm the worries of Taiwanese.
Taoyuan Mayor Cheng Wen-tsan (鄭文燦) and Tainan Mayor Huang Wei-che (黃偉哲), both of the Democratic Progressive Party, have said that they would be willing to receive the Medigen vaccine as their second shot, while New Taipei City Mayor Hou You-yi (侯友宜) of the Chinese Nationalist Party (KMT) has said that the jab’s efficacy should first be determined by the scientific community, not by politics.
Transparency is key to winning public support, Hou said, adding that public support is key to whether the Medigen jab would become widely accepted.
Additional reporting by Lai Hsiao-tung
Seven of the 17 NT$10 million (US$311,604) winning receipts from the November-December uniform invoice lottery remain unclaimed as of today, the Ministry of Finance said, urging winners to redeem their prizes by May 5. The reminder comes ahead of the release of the winning numbers for the January-February lottery tomorrow. Among the unclaimed receipts was one for a NT$173 phone bill in Keelung, while others were for a NT$5,913 purchase at Costco in Taipei's Neihu District (內湖), a NT$49 purchase at a FamilyMart in New Taipei City's Tamsui District (淡水), and a NT$500 purchase at a tea shop in New Taipei City's
Taiwanese officials were shown the first of 66 F-16V fighter jets purchased by Taiwan from the United States, the Ministry of National Defense said yesterday, adding the aircraft has completed an initial flight test and is expected to be delivered later this year. A delegation led by Deputy Minister of National Defense Hsu Szu-chien (徐斯儉) visited Lockheed Martin’s F-16 C/D Block 70 (also known as F-16V) assembly line in South Carolina on March 16 to view the aircraft. The jet will undergo a final acceptance flight in the US before being delivered to Taiwan, the
The New Taipei Metro's Sanyin Line and the eastern extension of the Taipei Metro's Tamsui-Xinyi Line (Red Line) are scheduled to begin operations in June, the National Development Council said today. The Red Line, which terminates at Xiangshan Station, would be connected by the 1.4km extension to a new eastern terminal, Guangci/Fengtian Temple Station, while the Sanyin Line would link New Taipei City's Tucheng and Yingge stations via Sanxia District (三峽). The council gave the updates at a council meeting reviewing progress on public construction projects for this year. Taiwan's annual public infrastructure budget would remain at NT$800 billion (US$25.08 billion), with NT$97.3
Deliveries of delayed F-16V jets are expected to begin in September, Minister of National Defense Wellington Koo (顧立雄) said today, after senior defense officials visited the US last week. The US in 2019 approved a US$8 billion sale of Lockheed Martin F-16 jets to Taiwan, a deal that would take the nation’s F-16 fleet to more than 200 jets, but the project has been hit by issues including software problems. Koo appeared today before a meeting of the legislature’s Foreign Affairs and National Defense Committee, which is discussing different versions of the special defense budget this week. The committee is questioning officials today,